APD - Air Products and Chemicals, Inc.
NYSE
->
Basic Materials
->
Specialty Chemicals
Allentown,
United States
Type: Equity
APD price evolution
APD
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2375.7 | $2535 | $1962.6 | |
| Short term investments | $61.8 | $102.8 | $271.8 | |
| Net receivables | $1821.6 | $2313.6 | $2435 | $2499 |
| Inventory | $766 | $755.6 | $721.2 | $709.3 |
| Total current assets | $6363 | $5677.4 | $6057.3 | $5649.5 |
| Long term investments | $6365.2 | $6427.1 | $6290.2 | |
| Property, plant & equipment | $24418.6 | $22464.2 | $20999.3 | $19914.3 |
| Goodwill & intangible assets | $1189.5 | $1201.6 | $1238.5 | |
| Total noncurrent assets | $31296.9 | $29864.4 | $28468.7 | |
| Total investments | $6427 | $6529.9 | $6562 | |
| Total assets | $39574.6 | $36974.3 | $35921.7 | $34118.2 |
| Current liabilities | ||||
| Accounts payable | $2926.2 | $3168.6 | $2783 | $2717.9 |
| Deferred revenue | ||||
| Short long term debt | $1150 | $1121.8 | $234.4 | |
| Total current liabilities | $4179.6 | $4474.5 | $4061 | $3119.2 |
| Long term debt | $13533 | $13522 | $13152 | $12508.4 |
| Total noncurrent liabilities | $15812.8 | $15525.8 | $14869.9 | |
| Total debt | $14672 | $14273.8 | $12742.8 | |
| Total liabilities | $22538.1 | $20287.3 | $19586.8 | $17989.1 |
| Shareholders' equity | ||||
| Retained earnings | $17989.9 | $17690 | $17510 | |
| Other shareholder equity | $17036.5 | -$2391.1 | -$2275.9 | -$2120.3 |
| Total shareholder equity | $15101.3 | $14913.4 | $14873 | |
| (in millions $) | 30 Oct 2024 | 31 Dec 2023 | 30 Oct 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1617 | $2711 | $4468.9 | |
| Short term investments | $332.2 | $590.7 | $1331.9 | |
| Net receivables | $1821.6 | $2422.5 | $1794.4 | $2002.2 |
| Inventory | $766 | $651.8 | $514.2 | $453.9 |
| Total current assets | $6363 | $5200.5 | $6282.9 | $8376.3 |
| Long term investments | $5929.7 | $3936.9 | $2389.6 | |
| Property, plant & equipment | $24418.6 | $18446.1 | $14160.5 | $13254.6 |
| Goodwill & intangible assets | $1196.3 | $1170.5 | $1332.2 | |
| Total noncurrent assets | $26802 | $20909.7 | $18482.9 | |
| Total investments | $6261.9 | $4527.6 | $3721.5 | |
| Total assets | $39574.6 | $32002.5 | $27192.6 | $26859.2 |
| Current liabilities | ||||
| Accounts payable | $2926.2 | $2890.1 | $2771.6 | $2218.3 |
| Deferred revenue | ||||
| Short long term debt | $874.5 | $559 | $486.9 | |
| Total current liabilities | $4179.6 | $3895.8 | $3465.8 | $2799.1 |
| Long term debt | $13533 | $10062.4 | $7085.8 | $7150.3 |
| Total noncurrent liabilities | $12446.4 | $10024.4 | $9972.1 | |
| Total debt | $10936.9 | $7644.8 | $7637.2 | |
| Total liabilities | $22538.1 | $16342.2 | $14048.6 | $12771.2 |
| Shareholders' equity | ||||
| Retained earnings | $19545.7 | $17289.7 | $16520.3 | $15678.3 |
| Other shareholder equity | $17036.5 | -$2449.4 | $13144 | -$1515.9 |
| Total shareholder equity | $14312.9 | $13144 | $13539.7 | |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2985.5 | $2930.2 | $2997.4 | |
| Cost of revenue | $2005.6 | $1991.5 | $2067.2 | |
| Gross Profit | $979.9 | $938.7 | $930.2 | |
| Operating activities | ||||
| Research & development | $27 | $25.4 | $25.7 | |
| Selling, general & administrative | $235.4 | $240.6 | $238.4 | |
| Total operating expenses | $242.3 | $301.5 | $263.3 | |
| Operating income | $737.6 | $637.2 | $666.9 | |
| Income from continuing operations | ||||
| EBIT | $892.9 | $762.8 | $798.2 | |
| Income tax expense | $140.6 | $130.5 | $135.4 | |
| Interest expense | $55.7 | $59.9 | $53.5 | |
| Net income | ||||
| Net income | $696.6 | $572.4 | $609.3 | |
| Income (for common shares) | $696.6 | $572.4 | $609.3 | |
| (in millions $) | 30 Oct 2024 | 31 Dec 2023 | 30 Oct 2022 | 31 Jan 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $12100.6 | $12600 | $12698.6 | |
| Cost of revenue | $8833 | |||
| Gross Profit | $3931.9 | $3767 | $3360.1 | |
| Operating activities | ||||
| Research & development | $105.6 | |||
| Selling, general & administrative | $957 | |||
| Total operating expenses | $984.4 | $1272.4 | $947.6 | |
| Operating income | $2494.6 | |||
| Income from continuing operations | ||||
| EBIT | $3028.9 | |||
| Income tax expense | $944.9 | $551.2 | $500.8 | |
| Interest expense | $428.9 | $177.5 | $368.3 | |
| Net income | ||||
| Net income | $3828.2 | $2300.2 | $2256.1 | |
| Income (for common shares) | $2300.2 | |||
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $696.6 | $572.4 | $609.3 | |
| Operating activities | ||||
| Depreciation | $360.3 | $360.8 | $349.2 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $17.7 | $14.7 | $13.8 | |
| Total cash flows from operations | $1261.4 | $801.7 | $626.6 | |
| Investing activities | ||||
| Capital expenditures | -$1606.6 | -$1669.4 | -$1445.5 | |
| Investments | $43 | $91.8 | -$233 | |
| Total cash flows from investing | -$4919.2 | -$1547.8 | -$1560.4 | -$1665.6 |
| Financing activities | ||||
| Dividends paid | -$1564.9 | -$393.5 | -$389 | -$388.9 |
| Sale and purchase of stock | $0.5 | $0.4 | $5.3 | |
| Net borrowings | $407.5 | $1675.9 | $1776.5 | |
| Total cash flows from financing | $2615.4 | $135.2 | $1349.7 | $1362.8 |
| Effect of exchange rate | $19.8 | -$8.1 | -$18.6 | $21.8 |
| Change in cash and equivalents | $1362.7 | -$159.3 | $572.4 | $345.6 |
| (in millions $) | 30 Oct 2024 | 31 Dec 2023 | 30 Oct 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | $2300.2 | $2099.1 | ||
| Operating activities | ||||
| Depreciation | $1358.3 | $1321.3 | ||
| Business acquisitions & disposals | -$912 | -$86.5 | ||
| Stock-based compensation | $59.9 | $44.5 | ||
| Total cash flows from operations | $3205.7 | $3335.2 | ||
| Investing activities | ||||
| Capital expenditures | -$4626.4 | -$2464.2 | ||
| Investments | -$382.8 | -$188 | ||
| Total cash flows from investing | -$4919.2 | -$5916.4 | -$3857.2 | -$2732.9 |
| Financing activities | ||||
| Dividends paid | -$1564.9 | -$1496.6 | -$1383.3 | -$1256.7 |
| Sale and purchase of stock | $24 | $10.6 | ||
| Net borrowings | $3169 | -$283 | ||
| Total cash flows from financing | $2615.4 | $1609.6 | -$1000.6 | -$1420.9 |
| Effect of exchange rate | $19.8 | $6.5 | -$130.3 | $27.8 |
| Change in cash and equivalents | $1362.7 | -$1094 | -$1757.9 | -$784.1 |
News
Fundamentals
| Market cap | $65.16B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 222.31M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.52 |
| Quick ratio | 1.34 |